MTb	NN	B-NP	B-protein	Other	###	1	MTb	MTb	NN	NN	_	2	nsubj	_	_
increases	VBZ	B-VP	O	Other	###	2	increases	increases	VBZ	VBZ	_	0	root	_	_
NFAT5	NN	B-NP	B-RNA	B-Protein	###	3	NFAT5	NFAT5	NN	NN	_	5	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	4	mRNA	mRNA	NN	NN	_	5	compound	_	_
levels	NNS	I-NP	O	Other	###	5	levels	levels	NNS	NNS	_	2	dobj	_	_
in	IN	B-PP	O	Other	###	6	in	in	IN	IN	_	8	case	_	_
human	JJ	B-NP	O	Other	###	7	human	human	JJ	JJ	_	8	amod	_	_
MDM	NN	I-NP	O	Other	###	8	MDM	MDM	NN	NN	_	5	nmod	_	_

Given	VBN	B-VP	O	Other	###	1	Given	Given	VBN	VBN	_	18	case	_	_
that	IN	B-SBAR	O	Other	###	2	that	that	IN	IN	_	18	mark	_	_
macrophages	NNS	B-NP	B-cell_type	Other	###	3	macrophages	macrophages	NNS	NNS	_	18	nsubj	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	3	punct	_	_
which	WDT	B-NP	O	Other	###	5	which	which	WDT	WDT	_	9	nsubj	_	_
are	VBP	B-VP	O	Other	###	6	are	are	VBP	VBP	_	9	cop	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	9	det	_	_
primary	JJ	I-NP	O	Other	###	8	primary	primary	JJ	JJ	_	9	amod	_	_
target	NN	I-NP	O	Other	###	9	target	target	NN	NN	_	3	acl:relcl	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	12	case	_	_
MTb	NN	B-NP	O	Other	###	11	MTb	MTb	NN	NN	_	12	compound	_	_
infection	NN	I-NP	O	Other	###	12	infection	infection	NN	NN	_	9	nmod	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	3	punct	_	_
are	VBP	B-VP	O	Other	###	14	are	are	VBP	VBP	_	18	cop	_	_
also	RB	B-ADVP	O	Other	###	15	also	also	RB	RB	_	18	advmod	_	_
a	DT	B-NP	O	Other	###	16	a	a	DT	DT	_	18	det	_	_
major	JJ	I-NP	O	Other	###	17	major	major	JJ	JJ	_	18	amod	_	_
reservoir	NN	I-NP	O	Other	###	18	reservoir	reservoir	NN	NN	_	30	advcl	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
HIV-1	NN	B-NP	O	Other	###	20	HIV-1	HIV-1	NN	NN	_	18	nmod	_	_
as	IN	B-SBAR	O	Other	###	21	as	as	IN	IN	_	23	mark	_	_
infection	NN	B-NP	O	Other	###	22	infection	infection	NN	NN	_	18	nmod	_	_
progresses	VBZ	B-VP	O	Other	###	23	progresses	progresses	VBZ	VBZ	_	18	advcl	_	_
[	(	O	O	Other	###	24	[	[	(	(	_	23	xcomp	_	_
40	CD	B-NP	O	Other	###	25	40	40	CD	CD	_	26	nummod	_	_
]	)	O	O	Other	###	26	]	]	)	)	_	24	xcomp	_	_
,	,	O	O	Other	###	27	,	,	,	,	_	30	punct	_	_
we	PRP	B-NP	O	Other	###	28	we	we	PRP	PRP	_	30	nsubj	_	_
next	RB	B-ADVP	O	Other	###	29	next	next	RB	RB	_	30	advmod	_	_
investigated	VBD	B-VP	O	Other	###	30	investigated	investigated	VBD	VBD	_	0	root	_	_
whether	IN	B-SBAR	O	Other	###	31	whether	whether	IN	IN	_	34	mark	_	_
MTb	NN	B-NP	B-protein	Other	###	32	MTb	MTb	NN	NN	_	34	nsubj	_	_
is	VBZ	B-VP	O	Other	###	33	is	is	VBZ	VBZ	_	34	cop	_	_
able	JJ	B-ADJP	O	Other	###	34	able	able	JJ	JJ	_	30	ccomp	_	_
to	TO	B-VP	O	Other	###	35	to	to	TO	TO	_	37	mark	_	_
directly	RB	I-VP	O	Other	###	36	directly	directly	RB	RB	_	37	advmod	_	_
enhance	VB	I-VP	O	Other	###	37	enhance	enhance	VB	VB	_	34	xcomp	_	_
NFAT5	NN	B-NP	B-RNA	B-Protein	###	38	NFAT5	NFAT5	NN	NN	_	40	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	39	mRNA	mRNA	NN	NN	_	40	compound	_	_
expression	NN	I-NP	O	Other	###	40	expression	expression	NN	NN	_	37	dobj	_	_
in	IN	B-PP	O	Other	###	41	in	in	IN	IN	_	44	case	_	_
primary	JJ	B-NP	B-cell_type	Other	###	42	primary	primary	JJ	JJ	_	44	amod	_	_
human	JJ	I-NP	I-cell_type	Other	###	43	human	human	JJ	JJ	_	44	amod	_	_
MDM	NN	I-NP	I-cell_type	Other	###	44	MDM	MDM	NN	NN	_	40	nmod	_	_
.	.	O	O	Other	###	45	.	.	.	.	_	30	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
prepared	VBD	B-VP	O	Other	###	2	prepared	prepared	VBD	VBD	_	0	root	_	_
MDM	NN	B-NP	B-cell_type	Other	###	3	MDM	MDM	NN	NN	_	2	dobj	_	_
from	IN	B-PP	O	Other	###	4	from	from	IN	IN	_	7	case	_	_
five	CD	B-NP	O	Other	###	5	five	five	CD	CD	_	7	nummod	_	_
normal	JJ	I-NP	O	Other	###	6	normal	normal	JJ	JJ	_	7	amod	_	_
donors	NNS	I-NP	O	Other	###	7	donors	donors	NNS	NNS	_	2	nmod	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	2	punct	_	_
stimulated	VBD	B-VP	O	Other	###	9	stimulated	stimulated	VBD	VBD	_	2	conj	_	_
the	DT	B-NP	O	Other	###	10	the	the	DT	DT	_	11	det	_	_
cells	NNS	I-NP	O	Other	###	11	cells	cells	NNS	NNS	_	9	dobj	_	_
with	IN	B-PP	O	Other	###	12	with	with	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	13	the	the	DT	DT	_	15	det	_	_
MTb	NN	I-NP	O	Other	###	14	MTb	MTb	NN	NN	_	15	compound	_	_
lysate	NN	I-NP	O	Other	###	15	lysate	lysate	NN	NN	_	11	nmod	_	_
or	CC	O	O	Other	###	16	or	or	CC	CC	_	2	cc	_	_
left	VBD	B-VP	O	Other	###	17	left	left	VBD	VBD	_	2	conj	_	_
them	PRP	B-NP	O	Other	###	18	them	them	PRP	PRP	_	19	nsubj	_	_
unstimulated	JJ	B-ADJP	O	Other	###	19	unstimulated	unstimulated	JJ	JJ	_	26	amod	_	_
,	,	O	O	Other	###	20	,	,	,	,	_	2	punct	_	_
and	CC	O	O	Other	###	21	and	and	CC	CC	_	2	cc	_	_
measured	VBN	B-NP	O	Other	###	22	measured	measured	VBN	VBN	_	2	conj	_	_
NFAT5	NN	I-NP	B-protein	B-Protein	###	23	NFAT5	NFAT5	NN	NN	_	26	compound	_	_
gene	NN	I-NP	O	Other	###	24	gene	gene	NN	NN	_	26	compound	_	_
expression	NN	I-NP	O	Other	###	25	expression	expression	NN	NN	_	26	compound	_	_
levels	NNS	I-NP	O	Other	###	26	levels	levels	NNS	NNS	_	17	dobj	_	_
by	IN	B-PP	O	Other	###	27	by	by	IN	IN	_	30	case	_	_
quantitative	JJ	B-NP	O	Other	###	28	quantitative	quantitative	JJ	JJ	_	30	amod	_	_
real-time	JJ	I-NP	O	Other	###	29	real-time	real-time	JJ	JJ	_	30	amod	_	_
PCR	NN	I-NP	O	Other	###	30	PCR	PCR	NN	NN	_	26	nmod	_	_
at	IN	B-PP	O	Other	###	31	at	at	IN	IN	_	35	case	_	_
24	CD	B-NP	O	Other	###	32	24	24	CD	CD	_	35	nummod	_	_
and	CC	I-NP	O	Other	###	33	and	and	CC	CC	_	32	cc	_	_
48	CD	I-NP	O	Other	###	34	48	48	CD	CD	_	32	conj	_	_
hours	NNS	I-NP	O	Other	###	35	hours	hours	NNS	NNS	_	30	nmod	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	2	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	3	nsubj	_	_
also	RB	B-ADVP	O	Other	###	2	also	also	RB	RB	_	3	advmod	_	_
investigated	VBD	B-VP	O	Other	###	3	investigated	investigated	VBD	VBD	_	0	root	_	_
whether	IN	B-SBAR	O	Other	###	4	whether	whether	IN	IN	_	8	mark	_	_
HIV-1	NN	B-NP	O	Other	###	5	HIV-1	HIV-1	NN	NN	_	6	compound	_	_
infection	NN	I-NP	O	Other	###	6	infection	infection	NN	NN	_	8	nsubj	_	_
is	VBZ	B-VP	O	Other	###	7	is	is	VBZ	VBZ	_	8	cop	_	_
capable	JJ	B-ADJP	O	Other	###	8	capable	capable	JJ	JJ	_	3	ccomp	_	_
of	IN	B-PP	O	Other	###	9	of	of	IN	IN	_	10	mark	_	_
inducing	VBG	B-VP	O	Other	###	10	inducing	inducing	VBG	VBG	_	8	advcl	_	_
NFAT5	NN	B-NP	B-RNA	B-Protein	###	11	NFAT5	NFAT5	NN	NN	_	12	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	12	mRNA	mRNA	NN	NN	_	13	compound	_	_
synthesis	NN	I-NP	O	Other	###	13	synthesis	synthesis	NN	NN	_	10	dobj	_	_
by	IN	B-PP	O	Other	###	14	by	by	IN	IN	_	15	mark	_	_
infecting	VBG	B-VP	O	Other	###	15	infecting	infecting	VBG	VBG	_	10	advcl	_	_
MDM	NN	B-NP	B-protein	Other	###	16	MDM	MDM	NN	NN	_	15	dobj	_	_
with	IN	B-PP	O	Other	###	17	with	with	IN	IN	_	24	case	_	_
live	JJ	B-NP	O	Other	###	18	live	live	JJ	JJ	_	24	amod	_	_
or	CC	I-NP	O	Other	###	19	or	or	CC	CC	_	18	cc	_	_
heat	JJ	I-NP	O	Other	###	20	heat	heat	JJ	JJ	_	18	conj	_	_
-	-	O	O	Other	###	21	-	-	-	-	_	18	punct	_	_
inactivated	JJ	I-NP	O	Other	###	22	inactivated	inactivated	JJ	JJ	_	18	conj	_	_
R5-tropic	JJ	I-NP	O	Other	###	23	R5-tropic	R5-tropic	JJ	JJ	_	24	amod	_	_
representatives	NNS	I-NP	O	Other	###	24	representatives	representatives	NNS	NNS	_	15	nmod	_	_
of	IN	B-PP	O	Other	###	25	of	of	IN	IN	_	27	case	_	_
subtype	NN	B-NP	O	Other	###	26	subtype	subtype	NN	NN	_	27	compound	_	_
B	NN	I-NP	O	Other	###	27	B	B	NN	NN	_	24	nmod	_	_
(	(	O	O	Other	###	28	(	(	(	(	_	29	punct	_	_
HIV-1Bal	NN	B-NP	O	Other	###	29	HIV-1Bal	HIV-1Bal	NN	NN	_	27	appos	_	_
)	)	O	O	Other	###	30	)	)	)	)	_	29	punct	_	_
,	,	O	O	Other	###	31	,	,	,	,	_	27	punct	_	_
C	NN	B-NP	O	Other	###	32	C	C	NN	NN	_	27	conj	_	_
(	(	O	O	Other	###	33	(	(	(	(	_	34	punct	_	_
HIV-198IN22	NN	B-NP	B-protein	Other	###	34	HIV-198IN22	HIV-198IN22	NN	NN	_	32	appos	_	_
)	)	O	O	Other	###	35	)	)	)	)	_	34	punct	_	_
,	,	O	O	Other	###	36	,	,	,	,	_	27	punct	_	_
or	CC	O	O	Other	###	37	or	or	CC	CC	_	27	cc	_	_
E	NN	B-NP	O	Other	###	38	E	E	NN	NN	_	27	conj	_	_
(	(	O	O	Other	###	39	(	(	(	(	_	40	punct	_	_
HIV-192TH64	NN	B-NP	O	Other	###	40	HIV-192TH64	HIV-192TH64	NN	NN	_	38	appos	_	_
)	)	O	O	Other	###	41	)	)	)	)	_	40	punct	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	3	punct	_	_

As	IN	B-SBAR	O	Other	###	1	As	As	IN	IN	_	2	mark	_	_
shown	VBN	B-VP	O	Other	###	2	shown	shown	VBN	VBN	_	12	advcl	_	_
in	IN	B-PP	O	Other	###	3	in	in	IN	IN	_	5	case	_	_
Figure	NN	B-NP	O	Other	###	4	Figure	Figure	NN	NN	_	5	compound	_	_
2A	NN	I-NP	O	Other	###	5	2A	2A	NN	NN	_	2	nmod	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	12	punct	_	_
stimulation	NN	B-NP	O	Other	###	7	stimulation	stimulation	NN	NN	_	12	nsubj	_	_
with	IN	B-PP	O	Other	###	8	with	with	IN	IN	_	10	case	_	_
MTb	NN	B-NP	O	Other	###	9	MTb	MTb	NN	NN	_	10	compound	_	_
lysate	NN	I-NP	O	Other	###	10	lysate	lysate	NN	NN	_	7	nmod	_	_
significantly	RB	B-ADVP	O	Other	###	11	significantly	significantly	RB	RB	_	12	advmod	_	_
increased	VBD	B-VP	O	Other	###	12	increased	increased	VBD	VBD	_	0	root	_	_
NFAT5	NN	B-NP	B-RNA	B-Protein	###	13	NFAT5	NFAT5	NN	NN	_	15	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	14	mRNA	mRNA	NN	NN	_	15	compound	_	_
levels	NNS	I-NP	O	Other	###	15	levels	levels	NNS	NNS	_	12	dobj	_	_
at	IN	B-PP	O	Other	###	16	at	at	IN	IN	_	17	case	_	_
24	CD	B-NP	O	Other	###	17	24	24	CD	CD	_	12	nmod	_	_
(	(	O	O	Other	###	18	(	(	(	(	_	20	punct	_	_
p	NN	B-NP	O	Other	###	19	p	p	NN	NN	_	20	nsubj	_	_
<	SYM	O	O	Other	###	20	<	<	SYM	SYM	_	17	dep	_	_
0.05	CD	B-NP	O	Other	###	21	0.05	0.05	CD	CD	_	20	nummod	_	_
)	)	O	O	Other	###	22	)	)	)	)	_	20	punct	_	_
and	CC	O	O	Other	###	23	and	and	CC	CC	_	17	cc	_	_
48	CD	B-NP	O	Other	###	24	48	48	CD	CD	_	17	conj	_	_
(	(	O	O	Other	###	25	(	(	(	(	_	28	punct	_	_
p	NN	B-NP	O	Other	###	26	p	p	NN	NN	_	28	dep	_	_
<	SYM	O	O	Other	###	27	<	<	SYM	SYM	_	28	dep	_	_
0.01	CD	O	O	Other	###	28	0.01	0.01	CD	CD	_	24	appos	_	_
)	)	O	O	Other	###	29	)	)	)	)	_	28	punct	_	_
hours	NNS	B-NP	O	Other	###	30	hours	hours	NNS	NNS	_	17	dep	_	_
,	,	O	O	Other	###	31	,	,	,	,	_	12	punct	_	_
whereas	IN	O	O	Other	###	32	whereas	whereas	IN	IN	_	44	mark	_	_
infection	NN	B-NP	O	Other	###	33	infection	infection	NN	NN	_	44	nsubj	_	_
with	IN	B-PP	O	Other	###	34	with	with	IN	IN	_	41	case	_	_
viable	JJ	B-NP	O	Other	###	35	viable	viable	JJ	JJ	_	33	nmod	_	_
or	CC	I-NP	O	Other	###	36	or	or	CC	CC	_	35	cc	_	_
heat	JJ	I-NP	O	Other	###	37	heat	heat	JJ	JJ	_	35	conj	_	_
-	-	O	O	Other	###	38	-	-	-	-	_	39	punct	_	_
inactivated	JJ	I-NP	O	Other	###	39	inactivated	inactivated	JJ	JJ	_	35	conj	_	_
HIV-1	NN	I-NP	O	Other	###	40	HIV-1	HIV-1	NN	NN	_	41	compound	_	_
isolates	NNS	I-NP	O	Other	###	41	isolates	isolates	NNS	NNS	_	33	nmod	_	_
did	VBD	B-VP	O	Other	###	42	did	did	VBD	VBD	_	44	aux	_	_
not	RB	I-VP	O	Other	###	43	not	not	RB	RB	_	44	neg	_	_
increase	VB	I-VP	O	Other	###	44	increase	increase	VB	VB	_	12	parataxis	_	_
NFAT5	NN	B-NP	B-RNA	B-Protein	###	45	NFAT5	NFAT5	NN	NN	_	47	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	46	mRNA	mRNA	NN	NN	_	47	compound	_	_
levels	NNS	I-NP	O	Other	###	47	levels	levels	NNS	NNS	_	44	dobj	_	_
(	(	O	O	Other	###	48	(	(	(	(	_	50	punct	_	_
Figure	NN	B-NP	O	Other	###	49	Figure	Figure	NN	NN	_	50	compound	_	_
2A	NN	I-NP	O	Other	###	50	2A	2A	NN	NN	_	44	dep	_	_
)	)	O	O	Other	###	51	)	)	)	)	_	50	punct	_	_
.	.	O	O	Other	###	52	.	.	.	.	_	12	punct	_	_

Thus	RB	B-ADVP	O	Other	###	1	Thus	Thus	RB	RB	_	5	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	5	punct	_	_
MTb	NN	B-NP	B-protein	Other	###	3	MTb	MTb	NN	NN	_	5	nsubj	_	_
specifically	RB	B-ADVP	O	Other	###	4	specifically	specifically	RB	RB	_	5	advmod	_	_
enhances	VBZ	B-VP	O	Other	###	5	enhances	enhances	VBZ	VBZ	_	0	root	_	_
NFAT5	NN	B-NP	B-RNA	B-Protein	###	6	NFAT5	NFAT5	NN	NN	_	8	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	7	mRNA	mRNA	NN	NN	_	8	compound	_	_
expression	NN	I-NP	O	Other	###	8	expression	expression	NN	NN	_	5	dobj	_	_
in	IN	B-PP	O	Other	###	9	in	in	IN	IN	_	11	case	_	_
human	JJ	B-NP	O	Other	###	10	human	human	JJ	JJ	_	11	amod	_	_
MDM	NN	I-NP	O	Other	###	11	MDM	MDM	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	###	12	,	,	,	,	_	5	punct	_	_
and	CC	O	O	Other	###	13	and	and	CC	CC	_	5	cc	_	_
this	DT	B-NP	O	Other	###	14	this	this	DT	DT	_	15	det	_	_
response	NN	I-NP	O	Other	###	15	response	response	NN	NN	_	16	nsubj	_	_
continues	VBZ	B-VP	O	Other	###	16	continues	continues	VBZ	VBZ	_	5	conj	_	_
to	TO	I-VP	O	Other	###	17	to	to	TO	TO	_	18	mark	_	_
increase	VB	I-VP	O	Other	###	18	increase	increase	VB	VB	_	16	xcomp	_	_
for	IN	B-PP	O	Other	###	19	for	for	IN	IN	_	23	case	_	_
at	IN	B-NP	O	Other	###	20	at	at	IN	IN	_	21	case	_	_
least	JJS	I-NP	O	Other	###	21	least	least	JJS	JJS	_	22	nmod:npmod	_	_
48	CD	I-NP	O	Other	###	22	48	48	CD	CD	_	23	nummod	_	_
hours	NNS	I-NP	O	Other	###	23	hours	hours	NNS	NNS	_	18	nmod	_	_
post	JJ	B-ADJP	O	Other	###	24	post	post	JJ	JJ	_	26	amod	_	_
-	-	O	O	Other	###	25	-	-	-	-	_	23	punct	_	_
stimulation	JJ	B-ADJP	O	Other	###	26	stimulation	stimulation	JJ	JJ	_	23	dep	_	_
(	(	O	O	Other	###	27	(	(	(	(	_	29	punct	_	_
Figure	NN	B-NP	O	Other	###	28	Figure	Figure	NN	NN	_	29	compound	_	_
2A	NN	I-NP	O	Other	###	29	2A	2A	NN	NN	_	26	appos	_	_
)	)	O	O	Other	###	30	)	)	)	)	_	29	punct	_	_
.	.	O	O	Other	###	31	.	.	.	.	_	5	punct	_	_

